These differences appear to involve early carbohydrate modifications, as indicated by the absence of AGE-modified MIF in anti-AGE and anti-CML western blot analyses of the brain tissue lysates (Supplementary Figure S1A and S1B). This evidence concerns the gene MIF and chronic myelogenous leukemia, BCR-ABL1 positive.